Higher Studies: IIT Hyderabad Announces 3 New Industry-Oriented BTech Programmes  |  Leadership Instincts: Innovation Hub of IIT Hyderabad and ARAI sign MoU for India Specific AV Tech  |  International Edu News: Nobel Peace Prize Laureates of 20th Century  |  International Edu News: Nobel Peace Prize 2021 for Safeguarding Freedom of Expression  |  Finance: Nobel Prize-Economics: Empirical Modeling and Applications in Textile Industry  |  Science Innovations: Explaining Brown Dwarfs  |  Best Practices: ITIC Incubator at IIT Hyderabad to Promote Six Startups in Autonomous Navigation  |  Teacher Insights: Depressed Adolescents Muted in Reaction to Distressing Images  |  Leadership Instincts: A new Lab for Science in Diplomacy in Geneva  |  Parent Interventions: Parental Genes May Influence Child’s Educational Attainments  |  Education Information: Nobel Stories: a Throwback and Latest Updates   |  Teacher Insights: School Reopening: Online as well as Classroom Learning should go hand-in hand  |  Education Information: UCSF Starts New Organisation to Involve Students in Covid Research  |  International Edu News: Go Green, Go Paperless! Next-Gen Education goes Paperless.  |  National Edu News: Go Green, Go Paperless! Next-Gen Education goes Paperless.  |  
March 19, 2020 Thursday 11:37:36 AM IST

World’s first artificial pancreas app licensed for people with type 1 diabetes

International Edu News

The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes has been launched. The app is based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm.

The app - which Professor Hovorka hopes will become available on the NHS in the future - will take over much of the management of the condition. This is particularly important at night, when many people with type 1 diabetes experience potentially dangerous low blood glucose levels. The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.

The CamAPS FX app is backed by 13 years of clinical research carried out by Professor Hovorka and his research group at the Wellcome-MRC Institute of Metabolic Science. It is licensed for use by both adults and children with the condition and is the first artificial pancreas system to be licensed for use in pregnancy, or by young children aged one and above.

The commercial launch is a milestone in the journey towards a fully automated artificial pancreas for everyone with type 1 diabetes. Such technology will fundamentally change life with the condition by working with a range of insulin pumps and glucose monitors to lift the burden of managing a condition that is relentlessly unpredictable day and night. Professor Hovorka will continue refining the artificial pancreas through research into mealtime glucose control and improving ease of use.


The research behind the app has been funded by the type 1 diabetes charity JDRF, Diabetes UK, the National Institute for Health Research, the National Institutes of Health, Horizon 2020, and The Leona M and Harry B Helmsley Charitable Trust

The app is now available for UK users to download onto Android phones via the Amazon Appstore. The app is available on a subscription basis starting at £70 per month.


(Content Courtesy: https://www.cam.ac.uk/research/news/worlds-first-artificial-pancreas-app-licensed-for-people-with-type-1-diabetes-in-uk)



Comments